Northwire Canada EditionFriday, July 10, 2026
Sign inSubscribe
Northwire
⌕
NNX 0.035 +0.0% ABX 51.82 −0.8% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.90 +10.1% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.40 −0.5% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% NNX 0.035 +0.0% ABX 51.82 −0.8% TTS 2.50 +0.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.90 +10.1% TUNG 1.72 +1.8% LGO 1.00 −3.9% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.40 −0.5% SGZ 0.045 +0.0% S 0.160 +33.3% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0%
Financings

Burcon Announces Results of Shareholder Meeting

By The Northwire Desk — AI Analysis Feb 20, 2026 · 15:34 BU · 2.17 BURCON NUTRASCIENCE CORPORATION J
BU · Price

Executive Summary

  • Shareholders approved resolutions for Burcon’s private placement of convertible debentures and the amendment to the expiry date of insiders’ outstanding warrants at its 2026 special meeting.
  • The company expects to close the convertible debenture financing on or about February 24, 2026.
  • A detailed voting results report has been filed on SEDAR+.

Key Details

  • Financing Structure: Private placement of convertible debentures (terms not disclosed in this release).
  • Warrant Amendment: Extension of the expiry date for outstanding insider warrants was approved.
  • Shareholder Approval: Resolutions were duly approved by shareholders, with disinterested shareholder approval obtained where required.
  • Closing Timeline: Anticipated closing of the convertible debenture financing is on or about February 24, 2026.
  • Reporting: Full voting results for each resolution are available on the SEDAR+ website (www.sedarplus.ca).

Notable Quotes

(No direct quotes were provided in the release.)

Read the original news release →

More from BURCON NUTRASCIENCE CORPORATION J

Jun 26, 2026 · 16:21

Stonegate updates coverage on Burcon Nutrascience Corporation (BU) 4Q26

Earnings Jun 24, 2026 · 16:12

494% revenue jump overshadowed by $14.3M loss, negative equity, and costly insider debt; liquidity a red flag.

Earnings Jun 16, 2026 · 08:01

Commercial scaling accelerates, but negative equity and explicit capital calls keep the risk/reward skewed to the downside.

Production / Operations Apr 20, 2026 · 08:01

Burcon NutraScience Ramps Production Amidst Cash Burn Concerns

Production / Operations Feb 27, 2026 · 20:10

Burcon closes $2.75M second tranche of placement

Financings Feb 27, 2026 · 16:38

Burcon Closes Second Tranche of Non-Brokered Private Placement of Convertible Debentures of up to $6.9 Million

Financings